Apr 15, 2020 8:00am EDT Ensysce, a California Based Biotech Company With a Mission to Solve the Opioid Crisis, Exploring a Treatment for COVID-19.
Sep 26, 2019 8:00am EDT Ensysce Biosciences Receives Multi-Year NIH HEAL Grant to Develop a Novel Opioid-Use-Disorder (OUD) Medication
May 10, 2019 9:41am EDT Ensysce Biosciences to Present Novel TAAPTM and MPARTM Opioid Technology at SMi 19th Annual Pain Therapeutics Conference May 14, 2019
Apr 16, 2019 8:00am EDT Ensysce Biosciences Announces Key Additions to Executive Team Ahead of Financing
Sep 17, 2018 8:00am EDT Ensysce Biosciences Receives Multi-Year NIDA Grant to Study and Deliver Opioid Overdose Protection
Sep 04, 2018 8:00am EDT Ensysce Biosciences to Present Novel TAP Opioid Technology at 7th Annual Gateway Investor Conference September 5, 2018
Jun 11, 2018 8:00am EDT Ensysce Biosciences to Participate in New Generation Analgesics Symposium at Annual Meeting of the College on Problems of Drug Dependence
Jan 29, 2018 8:00am EST Ensysce Biosciences Inc. Receives Fast Track Designation for PF614, BIO-MD™ Abuse Deterrent Extended Release Oxycodone Prodrug